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Abstract
Unintended pregnancy is a serious problem that can result in a host of negative consequences for
parents and children. A new long-acting reversible contraceptive could increase male
contribution to family planning, and thus reduce the high rates of unintended pregnancy seen
today. Vasalgel is one such contraceptive that is currently being developed in the United States.
The current study used the Health Belief Model (HBM), with additional variables of
interpersonal factors and social norms, as a basic framework to investigate men’s attitudes
towards and willingness to use Vasalgel. In the context of this study, the HBM suggests that
behavior is a function of two factors: the value an individual places on pregnancy avoidance, and
the individual’s belief that a specific preventative action – getting Vasalgel – will achieve that
goal. Heterosexual men took an online survey in which they learned about Vasalgel and
answered questions related to the contraceptive and HBM constructs. Overall, men had positive
attitudes towards Vasalgel, and 41% of men had positive intent to use it if the contraceptive
became available. Analyses showed that the HBM was able to predict both attitudes towards and
intent to use Vasalgel, and that including perceived norms and interpersonal factors significantly
improved the model for intent to use Vasalgel but not for attitudes. The results indicate that a
new contraceptive would be used by the male population and underscores the utility of theorybased models in health research.
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Introduction
Approximately 38% of the 210 million pregnancies that occur throughout the world each
year are unintended1, a figure that is appallingly high (Sedgh, 2014). This is a serious problem,
as unintended pregnancies often have significant long-term negative health consequences for
both mother and child. Upon discovering they are pregnant, women have three options:
continuing the pregnancy, abortion, or alternative care-arrangements (e.g., adoption). Of all the
unintended pregnancies worldwide, an estimated 50% end in abortion (Sedgh, 2014). While
abortions in legal, sanitary spaces are generally safe, they can still cause lasting emotional and
physical strain such as depression, risk of subsequent preterm delivery (Thorp, Hartmann, &
Shadigan, 2003). What is even more concerning is that half of all abortions are performed
illegally; these operations pose a definitive threat to maternal survival (Sedgh, 2014). But what
can be done?
One proposed method of addressing the issue of unintended pregnancy is through
contraception (Klima, 1998). Contraception, also referred to as birth control, is an umbrella term
used to describe methods or devices designed to prevent pregnancy. There are many different
methods of contraception available today, and many of them are safe and effective if used
properly. Given the large range of contraceptive methods and devices (see Table 1), it is
surprising that rates of unintended pregnancies remain high. The numbers become less
surprising when viewed alongside the information that 26% of women in the world have an
unmet need for contraception, a percentage that rises to 73% in developing countries (Singh,
2012). A multitude of factors contribute to these unmet needs: high cost, lack of access, fear of

1

Although unintended pregnancies are certainly not always unwelcome, the term “unintended pregnancy” is used in
the literature to describe pregnancies that occur two or more years before desired and those that are not wanted by
the mother (Sedgh, Singh, & Hussain, 2014).
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side effects, and inadequate knowledge about methods (Singh, 2012; Dixon et al., 2014). In order
to make headway with against unintended pregnancy, these barriers must be addressed. It is of
critical importance that women receive reproductive health care and services. Close to 800
women die every day from preventable causes related to pregnancy and childbirth (World Health
Organization [WHO], 2014). While the global maternal mortality rate is half of what it was in
1990, this number remains unacceptably high. In order to reduce maternal mortality and
improve overall health, women need continuing and improved access to reproductive health care
(WHO, 2014). At this point, however, it is not enough to continue to address the reproductive
needs of only women.
Table 1
Comparison of contraceptive methods by sex

Female
Diaphragm
IUD
The 'Pill'
Morning-after pill
Birth control patch
Female condom
Vaginal ring (NuvaRing)
Birth control shot (Depo-Provera)
Birth control sponge (Today sponge)
Birth control implant
Tubal sterilization

Male
Condom
Vasectomy

Note. This list was taken from the Planned Parenthood website. Withdrawal, outercourse, fertility awareness-based
methods, breastfeeding as birth control, and abstinence are not included because these methods do not involve either
contraceptive devices or surgery, and as such are not relevant to the present study.

Even if access to contraceptive methods is improved through the removal of obstacles,
the role of men in reproductive health needs to be addressed. Present-day contraceptive
developments and family planning programs worldwide overwhelmingly target women
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(Kalmuss & Tatum, 2007). Both men and women contribute equally to pregnancy, and yet there
is a large discrepancy between the number and kinds of contraceptive methods available to men
versus those available to women – there are many more options and of greater variety for women
than for men (see Table 1). Additionally, most reproductive health services are offered in clinics
visited primarily by women, and offer limited services for men (Green et al., 2006). The narrow
focus of family planning programs on women has consequently led to the exclusion of males in
discussions of reproductive health, relegating men to the role of ‘sperm producers’ who do not
have a say in fertility control (Maharaj, 2000). Even though women are the ones who actually
become pregnant, they cannot be held solely responsible for their own reproductive health: men
are hugely influential in fertility and contraceptive use decisions (Maharaj, 2000; Gage, 1998).
And yet, despite findings that the involvement of men in reproductive health programs can
increase utilization (Greene et al., 2006; Ezeh, 1993), the focus of such interventions and
developments remains on women. In order to investigate why, it is necessary to go back to the
beginning of modern-day contraceptives.
The first modern contraceptives were barrier methods intended to prevent sperm from
passing through a woman’s cervix and reaching the uterus. Condoms are the classic example of
a barrier method, and remain today one of the only contraceptive devices available to men.
Diaphragms and cervical caps were among the first barrier methods of birth control available to
women2. These methods are reasonably effective with perfect use (95% and 75%, respectively),
but rely highly on proper user behavior and as such often fail to prevent pregnancy in real world
situations (Trussel et al., 2009). Vaginal sponges have also been popularly used to block and
absorb sperm, but are similarly ineffective to other barrier methods (80% effective with perfect

2

The female condom was approved for use in the United States in 1993 (Gollub, 2000).
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use, 75% with typical use). Even though barrier methods are not always effective, they are
vastly better than not using any device and do help women to control their family sizes (Trussel
et al., 2009).
For women, the path to safe, reliable contraception began with a small pill, taken daily.
The new pill was the first medical contraceptive available to women, and the first effective nonbarrier form of birth control. Approved for contraceptive use in 1960, the pill’s development and
marketing of was arguably one of the most important innovations in reproductive health in the
twentieth century (Dhont, 2010). It revolutionized the way the world saw both family planning
and women’s roles in society (Goldin & Katz, 2000). Ninety-one percent effective with typical
use, the pill enabled women to take almost complete control over their own fertility (Trussel,
2011). Indeed, over the years the pill’s effectiveness coupled with its ease of use has made it the
most popular contraceptive in the United States (Jones, Mosher, & Daniels, 2012). By 2010 four
out of every five sexually experienced women in the United States had used the pill at some
point (Daniels, Mosher & Jones, 2012). The pill has also influenced the global approach to
contraception and reproductive health, paving the way for other non-permanent long-term
methods of contraception, such as intrauterine devices (IUDs), the patch, injectibles (e.g., DepoProvera, injected once every three months), and vaginal rings. As a consequence of the
development of the first pill, women today have a large variety of highly effective contraceptive
methods open to them3.
There has been no such advance in contraceptive methods for men. The only nonbehavioral forms of contraception available to men today are condoms and vasectomies, two
3

Regrettably, the most reliable contraceptive methods available to women are hormonal and can have negative side
effects for the emotional and health- state of the women using them (e.g., mood swings, nausea, cramps, weight gain
or loss; Robinson et al., 2004).
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options that are both flawed. Condoms rely heavily on user behavior and require the interruption
of a highly sexually charged moment; additionally, many men and women consider them to be
uncomfortable (MacPhail & Campbell, 2001). While male condoms are 98% effective with
perfect use, probability of failure with typical use is 17% (Kost et al., 2008). Vasectomies,
although highly effective (Trussel, 2011), involve an operation that requires surgery and is not
recommended for men who might ever want children in the future (Sharlip et al., 2012)4. In
short, there is a huge discrepancy between the availability of safe and reliable contraceptive
methods available to men versus women.
This disparity is important because, as discussed above, birth control is essential in the
fight to reduce unintended pregnancies and their associated consequences. If men are excluded
from contraceptive discussion, they cannot contribute helpfully to conversations surrounding
reproductive health. A new form of long-acting reversible contraception for men could change
the global approach to reproductive health in a similar way that the pill did for women. Such a
development would certainly reduce unintended pregnancies, and could inspire an increased
inclusion of men in reproductive health programs, services, and policies – which would improve
overall reproductive and maternal health (Biddlecom & Fapohunda, 1998). There is promising
new contraceptive method for men, not yet on the market, that could provide such a spark.
Vasalgel
Vasalgel is a new, long-acting reversible contraceptive that is currently being developed
in the United States. It closely resembles RISUG (Reversible Inhibition of Sperm Under

4

Vasectomies are technically reversible, but reversals are not always successful and do not guarantee a return to
fertility (Belker et al., 1991).
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Guidance), which is in Phase III trials5 in India. The method involves the injection of a polymer
into the vas deferens (the duct that transports sperm from the testicle to the urethra). The
polymer acts as a semi-solid plug, preventing viable sperm from getting through the vas
deferens. This method is similar to and as effective as a vasectomy, except that the vas deferens
is not cut, and the process can be reversed at any time with a second injection (which dissolves
the polymer). Vasalgel does not affect the ability to ejaculate. In addition, as fluids can pass
through the polymer, chronic pain and sperm granulomas – common side effects of vasectomies
– are unlikely to occur (Lohiya et al., 2009). The contraceptive method that most closely
resembles Vasalgel is the IUD, a highly effective long-acting reversible contraceptive (LARC)
that is inserted into a woman’s uterus.
Vasalgel could provide a concrete way for men to become involved and take an active
role in family planning, if they would use it. However, there has been no research on the
likelihood that men would use Vasalgel if given the option, and little research on men’s attitudes
towards and willingness to use potential male LARCs.
Men and Contraception
The limited options that men have for contraception, in addition to their current exclusion
from reproductive health education and services, means that there has been insufficient research
into potential attitudes towards a new form of male contraception. A few studies have, however,
attempted to investigate whether men are interested in taking charge of their own fertility. These
studies have generally shown that men view new contraceptive developments favorably. Middle
and upper class men in the United States have been interested in a new form of male
5

In Phase III trials, a drug or treatment is given to a large group of people to confirm its effectiveness, monitor side
effects, and collect information that will allow the drug or treatment to be used safely among the public.
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contraception since the 1970s, when 70% of men interviewed in a study said that they would use
a newly developed male contraceptive (Keith et al., 1975). The most popular option was a once
a month shot or pill, but 19% indicated that they were in favor of an option for a reversible
vasectomy. However, it is important to note that all of the men interviewed were over 30 years
old and had higher levels of education than the general public (Keith et al., 1975). In fact, an
earlier study found that among lower-class married men in the south-east United States, 47%
objected to the mere idea of a male pill and 59% objected to vasectomies (Balswick et al., 1972).
Consistent with these findings, a survey of a wide variety of men – from high school and college
students to dentists and physicians –found that men who were either married, highly educated, or
both had more favorable attitudes toward developments in long-acting male birth control than
their counterparts. Married men tended have more positive attitudes toward a male birth control
pill than unmarried men, and education – long thought to create more liberal and egalitarian
social attitudes – was associated with more positive attitudes towards birth control (Weinstein &
Goebel, 1979). The above research indicates that while men of high socioeconomic status have
viewed new forms of male contraception favorably for decades, it is likely that their social and
marital statuses impacted their attitudes.
Although far from conclusive, the research from the 1970s suggests that men, particularly
those of education and a certain class, would not be wholly unreceptive to the development and
promotion of a new LARC designed for men. Thus, although men today have often been
excluded from discussions on fertility, it may be due to a lack of options rather than disinterest
on their part. Additionally, a recent cross-cultural survey on attitudes toward male fertility
control found that across nine countries and four continents, 55% of men expressed willingness
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to use a new method of male fertility control6. For the United States alone, the percentage of
men willing to try a new contraceptive shrank slightly to 49%. Higher education was again
significantly associated with more positive attitudes towards new methods of male contraception
(Heinemann et al., 2004)7. The available evidence suggests that more than half of all men would
try a new contraceptive; the development of such a method could alter how the world views
reproductive health and men’s roles in it.
Despite the fact that the aforementioned findings indicate that men would utilize a new
contraceptive, there are significant limitations to the research thus far. The majority of the
studies on men’s attitudes towards contraceptive developments (Weinstein & Goebel, 1979;
Balswick et al., 1972; Keith et al., 1975) were published more than 25 years ago. Moreover, the
previous research has been predominantly descriptive in nature; the investigations were not
based on theoretical models. Consequently, while these studies provide vital data about men’s
attitudes towards and willingness to use new contraceptives, they do not provide useful
information regarding psychosocial correlates that could be used to predict those same attitudes
and intentions. Without theoretical structure based on previous research, it is difficult to try to
understand health behavior, let alone predict it. The Health Belief Model (HBM) is a
psychological model that has been shown to effectively predict a variety of health behaviors
including contraceptive intentions and attitudes in women and men (e.g., Laraque et al, 1997),
and thus provides an appropriate framework for the present research.

6

This is the average of attitudes from all nine countries (France, Germany, Spain, Sweden, USA, Brazil, Mexico,
Argentina, and Indonesia). Attitudes varied significantly across cultures.
7
It is important to note that in their report of general “willingness to use,” Heinemann et al. (2004) did not
distinguish between different options for a male contraceptive (e.g., a male pill, monthly injection, yearly injection).
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Health Belief Model
To understand men’s attitudes towards and willingness to use Vasalgel, it is helpful to
address how other health behaviors and attitudes are examined. The HBM offers a good lens for
the present research, as the model has been shown in numerous studies to effectively predict
preventive health behaviors (e.g., Schnall, Rojas & Travers, 2015). As shown in Figure 1, the
model is based on five primary constructs: perceived susceptibility, perceived severity, perceived
benefits, perceived barriers, and self-efficacy (Glanz, Rimer, & Viswanath, 2008). According to
the HBM, an individual must first consider himself to be susceptible to a condition (perceived
susceptibility), in this case impregnating a woman. Second, he must believe that the condition
has potentially serious consequences (perceived severity); for example, children being financial
burden. Third, the individual must understand that the negative outcome, pregnancy, is
avoidable through the use of effective contraception (perceived benefits), and that he/she is
personally able to perform this behavior (self-efficacy). These factors are then weighed against
the costs of using contraception (perceived barriers). The HBM suggests that once the threat of
pregnancy is recognized, if the perceived benefits of a contraceptive outweigh its perceived
costs, an individual is likely to use that contraceptive.
Although there has been no research linking the HBM to men’s attitudes towards and
willingness to use potential LARCs, there has been substantial research on the HBM and its
constructs as they relate to other contraceptive behaviors and attitudes in women and men (e.g.,
Laraque et al, 1997; Chernick et al., 2015). As such, the psychosocial constructs of the HBM
(perceived susceptibility, perceived severity, perceived barriers, perceived benefits, and selfefficacy) provide a useful framework that can be applied to the investigation of men’s attitudes
towards and willingness to use Vasalgel.
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Figure 1. Health Belief Model. The HBM provides an a priori framework for the model used in
this study. Socio-demographic variables are assumed to have an indirect effect on behavior by
influencing perceptions of the constructs of the HBM (susceptibility, severity, benefits, barriers,
and self-efficacy). The constructs in turn directly affect health behavior intentions.

Perceived susceptibility. The first component of the HBM is perceived susceptibility:
do men understand that they are capable of getting a woman pregnant if they have unprotected
sexual intercourse? The HBM suggests that individuals who feel at greater risk for unintended
pregnancy will be more likely to use effective methods of contraception. In support of this,
Condelli (1986) found that users of ‘the pill’ felt more susceptible to pregnancy from unprotected
sex than diaphragm users. As such, the former chose to adopt the pill because they knew it to be
more effective at preventing pregnancy.
Recent research involving women obtaining abortions in the United States found that the
majority of these women had, at the time of conception, believed that they could not get pregnant
(Frohwirth, Moore & Maniaci, 2013). Interestingly, even though the women understood
perfectly how pregnancy works, they still thought that it would not (or could not) happen to
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them. Women reported feeling invulnerable to pregnancy due to the perception that they or their
partners were barren, the fact that they could get pregnant did not occur to them, or the belief that
they were using a contraceptive method at the time.8 These feelings of insusceptibility were
significantly correlated with ineffective (or lack of) contraceptive use and subsequent
pregnancies (Frohwirth, Moore & Maniaci, 2013). These findings provide strong evidence that
perceived susceptibility to pregnancy influences contraceptive behavior.
Crucially, perceived susceptibility can only influence health behavior change when there
are negative consequences to not using contraception. In order for an individual to be motivated
to use contraception, he must view unintended pregnancy as a negative, rather than positive,
consequence. It is possible that men do not view unintended pregnancy as negatively as women,
given that they do not actually have to bear the child. Moreover, it is possible that men feel less
tied down by the thought of a child, and as such the risks of unprotected sex and potential
unintended pregnancy may be less salient to them. To investigate this possibility and its effect
on contraceptive attitudes and intent, the second construct of the HBM is perceived severity.
Perceived severity. An essential part of the HBM, perceived severity measures how
serious an individual perceives the consequences of a particular health behavior to be. However,
in the case of unintended pregnancy it becomes necessary to deviate slightly from the standard
model. As noted in several studies, (e.g., Nathanson & Becker 1983; Unger, Molina & Teran,
2000), pregnancy is not always perceived as a negative consequence, regardless of intention. In
fact, some previous research utilizing the HBM to investigate pregnancy has altered the construct
of perceived severity to “perceived consequences.” As this study investigates contraception,
8

Women who claimed perceived contraceptive use as the reason they felt unsusceptible to pregnancy often
misunderstood the mechanics of contraception (for example, thinking that skipping a few birth control pills would
not influence the effectiveness of the pill).
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however, it will retain the original construct of perceived severity to pregnancy. Negative
consequences of unintended pregnancy include but are not limited to: inability to finish school,
having to raise a child when unprepared, delayed or lost career opportunities, having to become
financially independent, and being unable to fulfill life goals.
One way that the consequences of unintended pregnancy have been shown to relate to
contraceptive decision-making process concerns pregnancy ambivalence. Pregnancy
ambivalence refers to the mixed feelings that an individual can have towards getting pregnant or
impregnating another person, which in turn may lead to conflicting views on pregnancy.
Individuals who are ambivalent towards pregnancy do not view the possibility of unintended
pregnancy in a positive light, but neither do they perceive it as a severe negative consequence.
Importantly, this is not uncommon occurrence: in 2012, 53% of men and 36% of women
(between the ages 18-29) in the United States reported being ambivalent towards pregnancy
(Higgins, Popkin, & Santelli, 2012). As a result of mixed feelings, ambivalence towards
pregnancy in women has been shown to be strongly correlated with both less overall
contraceptive use and with having a gap in contraceptive use while remaining at risk for
pregnancy (Frost, Singh, & Finer, 2007). Furthermore, a later study found that pregnancy
ambivalence in men was strongly correlated with less overall and less consistent contraceptive
use. Compared to men who had clear intentions to avoid pregnancy, sexually active men who
were ambivalent toward pregnancy were significantly less likely to have used any method of
contraception in the previous month (Higgins, Popkin, & Santelli, 2012). These studies support
the inclusion of perceived severity of pregnancy in the HBM. The construct appears to
significantly impact contraceptive use and as such must be taken into account when investigating
contraceptive behavior.
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Perceived Benefits. Once levels of perceived severity and susceptibility have been
established, individuals must next understand that there is benefit to changing their behavior.
According to the HBM, if no benefits are perceived, no behavioral change can take place
(DiClemente, Salazar, & Crosby, 2013). The primary benefit of going to a doctor and getting
Vasalgel injected is the significantly reduced chance of impregnating a sexual partner. Vasalgel
is as effective as a vasectomy but completely reversible. Effective contraception has the benefit
of not having to deal with unintended pregnancy, not having to discuss the possibility of a
partner getting an abortion, and not ending up raising a child before ready. Furthermore, this
new form of contraception does not require the interruption of coitus, as do both condom use and
withdrawal. The HBM is concerned with how individuals understand these benefits.
Perceived benefits of birth control have significant impact on contraceptive behavior.
Among women in the United States at high risk of contracting HIV, perceived “pros,” or
benefits, of condom use were positively associated with self-reported condom use. Women who
scored higher on the perceived condom-use benefits scale were more likely to report using birth
control in general as well as using condoms with their main partner and other partners (Lauby et
al., 1998). Similarly, several studies have shown that individuals who believe that condoms are
effective in preventing HIV transmission are significantly more likely to report consistent
condom use (e.g., Hingson et al., 1990; Baiden & Rajulton, 2011)9. Given what we know from
the background literature, perceived benefits of Vasalgel are likely to significantly impact men’s
attitudes and intentions towards the contraceptive.

9

While this finding does not pertain specifically to pregnancy prevention, it does relate to contraceptive use and as
such is relevant to the present research.
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Perceived Barriers. When investigating the benefits of a change in health behavior, it is
necessary to look at costs as well. The HBM is based on the assumption that when an individual
perceives a threat to their health, behavior change can occur if the perceived benefits outweigh
the costs, or barriers (DiClemente, Salazar, & Crosby, 2013). Possible barriers to men’s
intentions towards Vasalgel may include those barriers found to affect the use of other
contraceptive methods: fear of pain or needles (Bharadwah et al., 2012), perceived side effects
(Bharadwaj et al., 2012), and perceived structural barriers (e.g., lack of knowledge or financial
means; Leeman, 2007).
Fear of pain. The first barrier that might affect men’s willingness to try Vasalgel is fear
of pain, something that most humans share regardless of culture or upbringing. Needles have
significantly different connotations across different countries and societies, however. In the
United States and most Western societies, vaccines and shots are thought to be “necessary evils”;
negative, painful, and only sometimes effective. In several Eastern societies (e.g., parts of Asia),
shots are seen as essential to healing and as such are considered both necessary and desirable
(Concepción et al., 1991). One example of the way the Western world associates needles with
pain can be seen in the effect that fear of pain has on women’s decisions to use LARCs. Among
young, sexually active women in North London, for example, fear of pain was the most powerful
deterrent to using LARCs, more influential even than fear of side effects or potential damage to
future fertility (Bharadwah et al., 2012). Fear of needles and pain was also found to be a
significant disincentive for IUD use in a study of 500 adult women in the United States,
indicating the widespread repercussions of this fear (Bracken & Graham, 2007).
Women are not alone in allowing fear of pain to guide their decisions, however. Fear of
needles was able to significantly predict non-willingness to undergo a vasectomy among male
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heads of households in Kenya (Odhiambo, 2014). Pain, therefore, is a significant deterrent in
contraceptive decisions in both men and women. As Vasalgel involves an injection into a
sensitive part of the body, it is vital to investigate how fear of pain affects men’s willingness to
participate.
Perceived side effects. Although there are no known side effects to Vasalgel, men may
still worry about as yet unknown side effects, as well as potential long-term consequences of the
injection – for example, fear that they will not be able to ejaculate or that the contraceptive is not
actually reversible. Fear of side effects and concerns about lasting effects on fertility have been
found to be powerful disincentives to the adoption of LARC for women (Bracken & Graham,
2014), as has fear of side effects of injection generally (Bharadwaj et al., 2012).
Structural. A third barrier often included in health research is the perception of structural
barriers. Whether from economic inequalities or poor infrastructure barring access to clinics,
structural barriers often affect health behaviors (for a review of structural barriers to HIV
prevention, see; Parker, Easton, & Klein, 2000). One structural barrier to Vasalgel use may be
fear of not being able to afford the contraceptive or that insurance would not cover it. Even
though Vasalgel has not reached the market, it is still appropriate to measure men’s perception of
potential structural barriers to using the contraceptive. If they see structural barriers to the use of
Vasalgel even before it is a viable option, they may be less likely to explore the option if it
becomes available, or to indicate intent to use the contraceptive.
Self-Efficacy. The final psychosocial level of the HBM states that in order to enact
behavioral change, an individual must believe that he or she is capable of taking action (Glanz,
Rimer, & Viswanath, 2008). An individual must believe that engaging in a particular behavior
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will achieve a desired outcome, and in his or her ability to perform that behavior. The belief in
one’s own capacity to perform a behavior is referred to as self-efficacy. Self-perception of one’s
capabilities is often more predictive of behavior change than actual ability to make the change,
and as such is a vital component of the HBM.
The connection is generally supported by literature regarding the influence of selfefficacy on contraceptive use. Research into the relationship between self-efficacy and teenage
girls’ contraceptive behavior has found that girls with low contraceptive self-efficacy,
significantly more than girls with high contraceptive self-efficacy, described conflicted feelings
regarding sexual activities, which in turn contributed to self-reported ineffective and inconsistent
contraceptive use (Strecher et al., 1986). Additionally, contraceptive self-efficacy was found to
be a significantly predictive factor for intentions to use condoms in a large sample of male and
female college students; students who reported higher contraceptive self-efficacy were more
likely to report intent to use condoms in the future (Joffe and Radius 1993). Furthermore, among
unmarried, female, and sexually active college students, contraceptive self-efficacy has been
found to be significantly associated with effective contraceptive use (Heinrich, 1993). More
recently, contraceptive self-efficacy was found to be a significant predictor of positive intent to
use condoms in sexually inexperienced adolescents and of reported consistency of condom use in
sexually experienced adolescents (Baele, Dusseldorp and Maes 2001).
Longmore et al. (2003) found that adolescents of both sexes who had higher contraceptive
self-efficacy were also more likely to use a contraceptive method (condom or other) than to use
no method of contraception. Thus, contraceptive self-efficacy was able to effectively predict
contraceptive use regardless of method (Longmore et al. 2003). This finding, in conjunction
with the extensive research on how contraceptive self-efficacy pertains to condom-use, provides
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convincing evidence that self-efficacy as a psychological construct can predict contraceptive
intentions and use.
Limitations of the Health Belief Model
Although the HBM has had remarkable success at predicting health behaviors, there are
some limitations to the model. The first limitation of the HBM is that it fails to address the
impact that others’ approval – or disapproval – may have on health behavior, and consequently
fails to account for behavior that is influenced by societal norms (Sheeran & Abraham, 1996).
Perceived social norms, although not included in the standard HBM, are an integral part of many
health-related behaviors. Studies on a variety of health behaviors have found that the more an
individual feels social pressure or social support to perform a behavior, the more likely he or she
is to perform that behavior (e.g., intent to speed; Cestac, Paran & Delhomme, 2011, regular
exercise; Pender & Pender, 1986, and binge drinking; Johnston & White, 2003). As sexuality is
deeply affected by culture and societal norms, perceived norms are particularly important to take
into account when researching contraceptive behavior. Social norms have indeed been shown to
influence contraceptive behaviors (Fekadu & Kraft, 2001), and may predict attitudes and
intentions towards Vasalgel.
Perceived social norms have been added to the HBM in previous studies to create the best
possible model for contraceptive behavior. For example, perceived social support was an
important factor among women of reproductive age in the United States in their decision to adopt
either “the pill” or a diaphragm as their primary contraceptive method in the 1980s (Condelli,
1986). As would be expected, both pill and diaphragm users perceived high social support for
their respective chosen methods; however, while pill users did not perceive any social opposition
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for using a diaphragm, diaphragm users expected significant outside resistance to choosing the
pill. Perceived societal opposition was thus a probable significant factor in preventing
diaphragm users from adopting the pill as a contraceptive method, even though the pill is a much
more reliable form of contraception than the diaphragm (Condelli, 1986). Furthermore, men and
women in St. Lucia who believed that their friends used condoms were found to be significantly
more likely to report consistent condom use than individuals who believed that their friends did
not use condoms (Fishbein et al., 1993). There is strong support for the prediction that perceived
social support plays an intrinsic role in individual contraceptive decisions and behavior.
The second limitation of the HBM is that the model tends to isolate health decisions from
an individual’s ongoing relationships, such as those with a significant other or spouse (Gillam,
1991). Although the decision to use Vasalgel could potentially be made without regard for a
partner, contraceptive behaviors and decisions can never be fully investigated in isolation. The
interpersonal factor that is most likely to have an impact on contraceptive behavior is
communication with one’s sexual partner. In a meta-analysis of psychological factors that relate
to heterosexual condom use, communication with a partner about condoms and positive partner
attitude regarding condom use were both found to be positively correlated with more consistent
condom use (Sheeran, Abraham & Orbell, 1999). In addition, even though most adolescents
don’t discuss sexual issues with their partners, sexually active adolescents who communicated
about sexual issues with their partners were more likely to report consistent condom use
(Widman et al., 2013). Moreover, men and women who had had a sexual partner suggest using
condoms were significantly more likely to report condom use than individuals who had never
had a sexual partner suggest condom use (Fishbein et al., 1993). This is a strong indication that
partner communication influences actual contraceptive behavior. As contraceptive use is so
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often based on the decisions and beliefs of more than one person, it is necessary to take an
individual’s partner (if applicable) into account when investigating attitudes and intentions
toward any contraceptive method. As can be seen in Figure 2, perceived social norms and
interpersonal factors were added to the model of this study in order to address the limitations of
the HBM.

Figure 2. Representation of the current study’s model. HBM components are expected to predict
attitudes and intentions above and beyond the capabilities of participant characteristics, and interpersonal
and social norm factors are expected to improve the model even further.

Overview of the Current Study
There has been no study yet which uses a psychological framework to analyze men’s
attitudes and intentions towards Vasalgel or a similar male contraceptive method. At this point
in the field it is necessary to move away from research that is purely descriptive in nature and
towards established theory, in order to better understand and predict health behavior and attitudes
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related to contraception. In this way it will be possible to contribute to the previous research and
strengthen prior assumptions of the theoretical framework, if it is supported. The model used in
the current study is a modification of the HBM through the inclusion of social norms and
interpersonal factors. Additionally, no previous study has investigated men’s attitudes to a
tangible contraceptive development (named and previously publicized).
Rather than addressing unspecified male contraceptive developments as has been done in
previous research, this study investigates men’s attitudes and intentions towards a contraceptive
that is currently being developed, Vasalgel. There were several motives behind this decision.
First, Vasalgel has been publicized in multiple news sources, most notably The Guardian
(Valenti, 2014). This most likely increased the contraceptive’s tangibility, as some men may
have heard of it prior to participating in this study. Second, specifying the contraceptive should
prompt men to respond in a way that reflects their actual intentions were Vasalgel to hit the
market. Third, most of the previous literature on the HBM has dealt with behavior or behavioral
intentions that individuals could actually adopt or change. As such, asking about Vasalgel as
though it is a viable option should make the HBM more applicable to the current study.
Although Vasalgel is not on the market yet, it has a name and a specific description (provided to
men who participated in the survey). This is important because willingness to use LARCS has
been shown to depend on the kind of contraception being investigated, be it a male pill, injection,
or applied jelly. If Vasalgel (or another product) becomes available, it will have a specific name
and description, which will affect attitudes and intent to use. Research into contraceptive
methods has to take that knowledge into account.
The current study was conducted at Bard College and the surrounding towns of Dutchess
County. The decision to broaden the population sample of the study was both to expand the age
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range of potential participants and to investigate a wider range of opinions and contraceptive
beliefs. Bard College is a small liberal arts college (averaging 500 per class) with a relatively
homogenous student population (76% of the incoming class of 2019 held United States
citizenship). Given that Bard is primarily an undergraduate college, respondents from within the
college were expected to range in age from eighteen to twenty-four. According to the latest
census data, the median age of males in Dutchess County is 39 years (U.S. Census Bureau,
2010). To measure men’s attitudes and intent to use Vasalgel, male participants completed an
online survey, which asked them questions related to the constructs of the HBM, certain
interpersonal-level factors, and their perceived social norms.
Studies investigating intent to use and attitudes towards male contraceptive developments
are few. Consequently, this study utilized the basic framework of the HBM, which has been
used in the past to research a variety of contraceptive behaviors and intentions, with the inclusion
of the two addition independent variables of perceived social norms and interpersonal factors to
test the research hypotheses. The goal was to investigate how personal perceptions (of
susceptibility to pregnancy, severity of pregnancy, benefits of Vasalgel, barriers to use of
Vasalgel, contraceptive self-efficacy, and social norms) influence men’s attitudes and intentions
towards Vasalgel. Hence, the first hypothesis of this study is that the constructs of the HBM will
predict men’s attitudes and intent to use. The second hypothesis is that the inclusion of
interpersonal-level factors and perceived social norms will significantly improve the predictive
ability of the HBM, and therefore the model.
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Method
Participants
Study participants, all men, ranged in age from 18-48 (M = 24; SD = 5.5). One hundred
and forty-six participants completed the study survey. Three respondents were excluded from
subsequent analyses: two were outliers (their scores were more than 3 standard deviations from
the mean on one or both of the dependent variables), and one failed to answer any of the items
corresponding with the dependent variables. As such, final analyses were run with a total of 143
participants. All reported being biologically male, and all reported being interested in vaginal
sex with women. Fifty one percent (n = 74) were students, 46% (n = 67) reported being
employed, and 2.7% (n = 4) reported being unemployed at the time of taking the survey.
Seventy eight percent of the students who participated in the study were Bard students (n = 57).
Ninety percent of all participants (n = 130) reported having had sex with a woman, and 75% of
those men reported sexual activity in the previous month (n = 98). Fifty seven percent of all
participants were in an ongoing sexual relationship with a woman (n = 84). Of participants in
relationships, condoms (48%) and oral contraception (44%) were the most popular forms of
contraception used. The next most popular method was withdrawal (20%), followed by
intrauterine devices (8%). No participants reported using a diaphragm as a form of
contraception.
Measures
Socio-demographic measures. The first section of the survey measured sociodemographics. Participants were asked to indicate their age, highest level of education reached,
and current employment status (student, employed, unemployed). If participants reported being
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students, they were then prompted to specify which college or university they attended and their
current year in school. Participants were then asked a series of questions relating to their sexual
history (e.g., “Have you ever had sex with a woman?”). A full list of these items can be found in
Appendix A.
Interpersonal Factors. Participants were subsequently asked whether they were in a
current, ongoing sexual relationship with a woman (regardless of relationships with other men or
women). If they said “yes,” indicating that they were at that time in an ongoing sexual
relationship with a woman, they were then asked to rate, on a 6-point scale (1 = strongly
disagree, 6 = strongly agree), how well they communicate with their partner about birth control
(For items see Table 2).
Attitudes and intentions. Following demographic and interpersonal factor questions, a
brief description of Vasalgel was provided. Attitude towards Vasalgel was then measured by
asking participants to rate the following questions on a 6-point scale (1 = strongly disagree, 6 =
strongly agree): “I think that Vasalgel is an important invention,” and “Vasalgel should be put on
the market as soon as possible.” Participants were also asked to rate the statements: “I would use
Vasalgel if it became available,” on the aforementioned 6-point scale and “Using Vasalgel as a
long-term contraceptive method for me would be: [Very Awful, Awful, Somewhat Awful,
Somewhat Nice, Nice, Very Nice]” on a 6-point scale where 1 = Very Awful and 6 = Very Nice.
These two items were averaged to create a composite score, which characterized intent to use.
HBM constructs. Twenty-two separate items measured the constructs of the HBM
(perceived susceptibility, perceived severity, perceived benefits, perceived barriers, selfefficacy). Survey items that examined the constructs of the HBM were adapted from a study by
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Bish, Sutton, and Golombok (2000), which investigated whether the HBM could predict an
increase of routine cervical smear testing in women. Participants rated, on a 6-point scale (1 =
strongly disagree, 6 = strongly agree), how susceptible they felt to getting a woman pregnant
(e.g., “I cannot get a woman pregnant.10”) and how severe they believed the consequences of
impregnating a woman would be (e.g., “Getting a woman pregnant is one of the worst things that
could happen at this stage in my life.”). They were then asked to rate, on the same 6-point scale,
statements concerning benefits and barriers to the use of Vasalgel. An example of a statement
measuring perceived benefits was “I am confident Vasalgel is able to prevent pregnancy.” An
example of an item measuring perceived barriers to Vasalgel use was “I am worried about the
side effects of Vasalgel.” Contraceptive self-efficacy was measured using 6-point scales, asking
participants to rate how capable they felt of going to a doctor to get Vasalgel (regardless of
actual intent). Importantly, in order to accurately predict behavior change, self-efficacy
measures must relate specifically to the health behavior in question (for a review of self-efficacy in
health behaviors, see Strecher et al., 1986). This measure was therefore tailored specifically to

Vasalgel use (See Table 2).
Perceived social norms. Three items measured perceived social norms (rated on a scale
of 1-6, 1 = strongly disagree, 6 = strongly agree): “My family and friends would make fun of me
if I used Vasalgel,” “My male friends would encourage me to get Vasalgel if it became
available,” and “As far as I know, my male friends would be interested in using Vasalgel if it
became available.”

10

This item was reverse-coded.
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Table 2
Health Belief Model Items Grouped by Construct used to Asses Pregnancy and Vasalgel Use perceptions
Construct
Interpersonal Factors
I do not talk about birth control with my partner.*
I often feel embarrassed when talking about birth control with my partner.*
My partner is comfortable talking about birth control with me.
Susceptibility to Pregnancy
I cannot get a woman pregnant.*
My physical health makes it more likely that I won’t get a woman pregnant if we have unprotected sex.*
Severity of Pregnancy
Getting a woman pregnant is one of the worst things that could happen at this stage in my life.
I would be happy if I got a woman pregnant in the next six months.*
Problems I would experience from getting a woman pregnant would last a long time.
If I got a woman pregnant, my whole life would change.
The thought of impregnating a woman scares me.
If I got a woman pregnant my job opportunities and professional career would be endangered.
Benefits of Vasalgel
I am confident Vasalgel is able to prevent pregnancy.
Using Vasalgel would reduce my fear of getting a woman pregnant.
I have a lot to gain by using Vasalgel.
Barriers to Vasalgel Use
I am afraid that if I use Vasalgel it would affect my ability to have children later.*
I am worried about the side effects of Vasalgel.*
The fact that Vasalgel is injected into a sensitive part of my body would not deter me from using it.
I am afraid that getting Vasalgel would hurt me.*
I am not worried that getting Vasalgel would cause me to be permanently infertile.
I am afraid that Vasalgel would affect my sex drive.*
Self-efficacy of Vasalgel Use
It would be difficult to tell a partner that I am going to get Vasalgel.*
I am confident that I could go to the doctor to get Vasalgel if it became available.
I would not insist on getting Vasalgel if a partner threatened to leave me if I got it.*
I feel capable of discussing the importance of using Vasalgel with a sex partner.
I would get Vasalgel even if my partner did not want me to.
Social Norms regarding Vasalgel
My family and friends would make fun of me if I used Vasalgel.*
My male friends would encourage me to get Vasalgel if it became available.
As far as I know, my male friends would be interested in using Vasalgel if it became available.
* Items were reverse coded.
Note: Response categories are six points: (1) strongly disagree to (6) strongly agree.
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Procedure
Participants were recruited at Bard College and surrounding areas of the Hudson Valley
in New York State (Kingston, Rhinebeck, Red Hook, Tivoli, Hudson, and Catskill). Participants
at Bard College were recruited by through flyers on bulletin boards around campus and through
flyers on tables in Kline Commons. Recruitment in surrounding areas took place via flyers
posted in local businesses (e.g., cafes, stores, restaurants). Flyers noted that participants must be
male and over eighteen years old. Flyers advertised the link to the survey and the incentive,
which was the chance to win one of four $25 gift cards to Amazon.com. To see copies of the
flyers used, refer to Appendix B.
When participants entered the link to the online survey into their computers, the first
screen they saw was the informed consent form. After reading the consent form, participants
either clicked “Yes, I consent to participate,” or “No, I do not consent.” If they consented, they
were asked three screening questions: “Are you 18 years of age or older,” “Are you biologically
male,” and “Are you interested in having vaginal sex with a woman (or women)?” If
participants answered “no” to any of these questions, they were directed to a page thanking them
for their interest in the study, but telling them that they did not qualify for the study. If they
responded “yes” to all three screening questions, they were able to continue on to the rest of the
survey. Upon completing the survey, participants were redirected to a debriefing statement,
which informed participants of the purpose of the study, the availability of counseling services,
the method for entering the lottery to win a gift card, and resources where they could find more
information about contraception and Vasalgel.
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General Analysis
There were two dependent variables of interest: attitude toward and intent to use
Vasalgel. The independent variables were the constructs of the HBM (perceived susceptibility,
perceived severity, perceived benefits, perceived barriers, and self-efficacy), as well as the
additional constructs of interpersonal factors, and perceived social norms. Independent variables
were measured by separate subscales, each of which was comprised of several items. To create
composite scores and to generate a valid HBM global score, negatively worded items were
recoded so that high and low values would indicate the same type of response for each item. The
following survey items were reverse coded: 25, 26, 32, 36, 37, 40, 41, 45, 49, 52, 53, 55, 58, 59,
61, 64, and 69 (see Appendix A for corresponding items). In order to test for scale reliability, a
Cronbach’s alpha was run for each subscale of the HBM, as well as for the scales measuring
perceived social norms and interpersonal factors. Items that had intercorrelations under 0.3 (of
medium strength) were removed from the scales. Items 24, 35, 38, 40, 45, 48, 49, and 57 were
removed in order to improve internal consistency of the subscales. Refer to Appendix A for full
survey and Table 2 for subscale items used in the final analyses. For each independent variable,
a composite score was calculated by averaging the scores of individual items. A “global score”
was then calculated for the HBM by averaging the composite scores of the HBM subscales.
Data Analysis
To determine possible confounds, linear regressions (dependent variables: intent to use
and attitudes towards Vasalgel) were run on the following demographic variables: age, number
of sexual partners in the past year or ever, ever having had sex, contraception use at last sex,
current employment status, and currently being in a relationship, having children, and having
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heard of Vasalgel prior to taking the survey. Confounding variables found to impact the
dependent variables were included in subsequent regression models. To test for multicollinearity
between subscales, cross-correlations were run on all of the independent variables.
Two hierarchical multiple regressions were run to test how well the independent variables
predicted attitudes towards (dependent variable 1) and intent to use (dependent variable 2)
Vasalgel within the context of the full model of this study. Participant characteristics which
significantly impacted attitudes (Heard of Vasalgel previously) and intentions (Having children
and having heard of Vasalgel previously) towards Vasalgel were entered at Stage 1. At Stage 2,
the score on independent components of the HBM were entered to test the predictive power of
each construct within the setting of the model as a whole. Next, based on previous research
demonstrating the relevance of social norms (Condelli, 1986) and interpersonal-level factors
(Sheeran, Abraham & Orbell, 1999) to contraceptive behavior, these variables were entered at
Stage 3 to explore whether social norms and interpersonal factors significantly improved model
estimates of participants’ attitudes towards and intent to use Vasalgel above the HBM alone.
Results
Attitudes towards Vasalgel were predominantly favorable (M = 4.82), as were intentions
to use Vasalgel (M = 4.30). More specifically, 41% of all participants (n = 59) either moderately
or strongly agreed with the statement “I would use Vasalgel if it became available,” compared to
22% (n = 31) who either moderately or strongly disagreed. Interestingly, 57% of participants (n
= 82) reported that using Vasalgel would be for them “very nice” or “nice,” compared to only
0.06% (n = 9) who said it would be “awful” or “very awful.” Fifty-five percent (n = 79)
moderately or strongly agreed with the statement: “Vasalgel should be put on the market as soon
as possible,” and 0.06% (n = 9) moderately or strongly disagreed. Additionally, 78% of
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participants (n = 112) moderately or strongly agreed that “Vasalgel is an important invention,”
whereas only 0.03% (n = 4) moderately or strongly disagreed with the statement.
The only demographic characteristic that had a significant effect on both intent to use and
attitude towards Vasalgel was having heard of Vasalgel prior to the present study (n = 63).
Currently having children (n = 5) had a significant effect on intent to use, but not attitude. Age,
number of sexual partners in the past year or ever, ever having had sex, contraception use at last
sex, current employment status, and currently being in a relationship had no direct relationship
with intent to use or attitude. Mean scores and frequencies for participant characteristics are in
Table 3.
Although only having heard of Vasalgel prior to the study and having children were
shown to significantly impact attitude and/or intent to use, other demographic characteristics
were associated with certain HBM constructs and perceived social norms. Linear regressions
exploring the impact of participant characteristics on HBM constructs and perceived social
norms found that younger age was significantly associated with higher perceived severity
(F(1,140) = 24.83, p < 0.001). Having children was associated with lower perceived severity
(F(1,126) = 11.01, p < 0.01) and lower perceived benefits (F(1,125) = 4.08, p < 0.05).
Additionally, having heard of Vasalgel significantly increased perceived social norms (F(1,138)
= 26.93, p < 0.001), perceived benefits (F(1,138) = 42.53, p < 0.001), and perceived barriers11
(F(1,139) = 29.82, p < 0.001). There was a significant difference between employment groups
(student, employed, unemployed) as determined by one-way ANOVA (F(2,138) = 4.10, p <
0.05). A Tukey post-hoc revealed that students had significantly higher levels of perceived

11

The entirety of the perceived barriers scale was reverse-coded. Having heard of Vasalgel was associated with
lower levels of the non-reverse scored construct of perceived barriers.
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severity of pregnancy than employed individuals (p = 0.05). There were no significant
differences between perceived severity of non-employed and employed individuals (p = 0.82) or
non-employed individuals and students (p = 0.98).
Table 3
Participant characteristics
Characteristic
Total (N = 143)
Range
Age [mean (SD)]
24.31 (5.51)
18 - 48
Sexual partners this year [mean (SD)]
2.28 (8.29)
0 - 25
Sexual partners ever [mean (SD)]
8.29 (8.07)
0 - 40
Current employment status [n (%)]
Student
73 (51)
Employed
65 (45.5)
Unemployed
4 (2.8)
Ever had sex [n (%)]
Yes
129 (90.2)
No
13 (9.1)
Contraception use at last sex [n (%)]
Yes
111 (77.6)
No
17 (11.9)
Currently has children [n (%)]
Yes
5 (3.5)
No
124 (86.7)
Currently in sexual relationship [n (%)]
Yes
82 (57.3)
No
46 (32.2)
Heard of Vasalgel previously [n (%)]
Yes
63 (44.1)
No
79 (55.2)
Note: Percentages do not add up to 100 in all cases as they are calculated from the total sample, not only
of participants who answered a particular question.

Internal consistency (Cronbach’s alphas) for the subscales of perceived severity,
perceived benefits, perceived barriers, and self-efficacy were above 0.70, indicating good scale
reliability (George & Mallery, 2003). Cronbach’s alphas for the perceived susceptibility,
perceived social norms, and interpersonal factors scales were below 0.7, which suggests
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questionable internal consistency (see Table 4 for full list of Cronbach’s alphas). However,
given the centrality of these measures to this study, regression analyses retained these factors.
Table 4
Cronbach's Alphas for Subscales of HBM and Social Norms and
Interpersonal Factors Scales
Construct
Cronbach's Alpha
Items
Perceived Susceptibility
0.59
2
Perceived Severity
0.77
6
Perceived Benefits
0.78
3
Perceived Barriers
0.83
6
Self-efficacy
0.73
5
Perceived Social Norms
0.66
3
Interpersonal Factors
0.60
3

Means for the composite scores of HBM subscales and scales of interpersonal factors
were generally high (above 4.0), with the exception of that of perceived barriers (3.34; see Table
5 for full list of means). Higher scores indicate stronger agreement with items in the scale.
Table 5
HBM subscales, interpersonal factors, and
perceived social norms
Construct
Mean (SD)
Perceived Susceptibility
5.77 (0.55)
Perceived Severity
5.94 (1.10)
Perceived Benefits
4.47 (1.09)
Perceived Barriers
3.34 (1.07)
Self-efficacy
4.08 (0.97)
Perceived Social Norms
4.18 (1.00)
Interpersonal Factors
5.39 (0.79)
Note: Scale responses ranged from 1 = completely disagree to 6 = completely agree. The construct of
perceived barriers was reverse coded for the purpose of analysis.

There were significant correlations between several of the composite scores for
components of the HBM, perceived social norms, and interpersonal-level factors. These
correlations and significance levels are reported in full in Table 6.
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Table 6
Correlation matrix of HBM constructs, perceived social norms, and interpersonal factors
Construct
1
2
1 Perceived Susceptibility
2 Perceived Severity
0.11
3 Perceived Benefits
0.15
0.34*
4 Perceived Barriers
0.11
0.09
5 Self-efficacy
0.11
0.16
6 Perceived Social Norms
0.15
0.11
7 Interpersonal Factors
0.12 -0.11
* Correlations are significant to the level of p < 0.01

3

4

5

6

0.58*
0.57*
0.54*
0.14

0.48*
0.46*
0.14

0.57*
0.15

0.18

Two three stage hierarchical multiple regressions were conducted with attitude and intent to use
as the dependent variables. Control variables were entered at stage one of the regression. There
was one control variable for attitude (having heard of Vasalgel prior to this study) and two
control variables for intent to use (having heard of Vasalgel previously and currently having
children. For hierarchical regressions on both intent to use and attitude, HBM variables were
entered at stage two, and interpersonal and perceived social norm variables were entered at stage
three. Regression statistics for intent to use are reported in Table 7, and for attitude in Table 8.
Hypothesis 1: The HBM can predict intent and attitude towards Vasalgel
Results of the regression analyses provided confirmation for the first research hypothesis. The
hierarchical multiple regressions for both intent to use and attitude revealed that at step two,
HBM variables contributed significantly to the model (attitude, step 2: F(6,73) = 12.61, R2 =
0.51, p < 0.001; intent, step 2; F(7,71) = 22.17, R2 = 0.69, p < 0.001) above and beyond any
participant characteristics (see Tables 7 and 8 for model comparison statistics).
At step 2 for intent to use Vasalgel, the HBM constructs that independently contributed
significantly to the model were: self-efficacy (t(78) = 2.46, p < 0.05), perceived benefits (t(78) =
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3.25, p < 0.01), and perceived barriers (t(78) = 2.52, p < 0.05). At step 2 for attitudes towards
Vasalgel, only perceived benefits contributed significantly to the model independently of the
other subscales of the HBM (t(79) = 0.95, p < 0.001). Refer to Table 7 for full regression
statistics for intent to use and Table 8 for attitude.
Hypothesis 2: Interpersonal factors and perceived social norms increase the HBM’s
predictive capacity
Interpersonal and perceived social norm variables were entered at step three. The inclusion of
these variables significantly improved model predictions for intent to use Vasalgel (full model:
F(9,69) = 19.37, R2 = 0.72, p < 0.001), but did not significantly affect the predictive ability of the
model for attitude (full model: F(8,71) = 9.30, R2 = 0.51, p = 0.82; see Tables 7 and 8 for model
comparison statistics). Additionally, although the full model for intent to use Vasalgel was
significant, at step three only the addition of social norms (not interpersonal factors) individually
contributed significantly to the model (t(78) = 2.69, p < 0.01).
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Table 7
Hierarchical model (Intent to use): Effect of having children, previous knowledge of
Vasalgel, HBM constructs, interpersonal factors, and perceived social norms on intent to
use Vasalgel
Unstandardized
estimate (SE)
Step 1
Intercept
Have children?
Heard of Vasalgel previously
Step 2
Intercept
Have children?
Heard of Vasalgel previously
Perceived Susceptibility
Perceived Severity
Perceived Benefits
Perceived Barriers
Self-efficacy
∆R2 = 0.38 ∆F = 17.08 p = 0.01
Step 3
Intercept
Have children?
Heard of Vasalgel previously
Perceived Susceptibility
Perceived Severity
Perceived Benefits
Perceived Barriers
Self-efficacy
Perceived Social Norms
Interpersonal Factors
∆R2 = 0.03 ∆F = 3.70 p = 0.03
* p < 0.05
** p < 0.01

5.01 (1.35)
0.82 (0.61)
-1.41 (0.27)
0.32 (1.62)
0.91 (0.46)
-0.22 (0.23)
-0.28 (0.21)
-0.11 (0.09)
0.47 (0.13)
0.34 (0.12)
0.39 (0.12)

0.24 (1.67
0.68 (0.46)
-0.22 (0.23)
-0.24 (0.20)
-0.08 (0.09)
0.42 (0.13)
0.28 (0.11)
0.30 (0.12)
0.29 (0.11)
-0.06 (0.12)

Standardized
estimate

t-value

0.13
-0.51

3.7**
1.33
-5.25*

0.14
-0.08
-0.09
0.09
0.37
0.27
0.29

0.2
1.95
-0.094
-1.33
-1.2
3.54**
2.89**
3.28**

0.11
-0.08
-0.08
-0.07
0.33
0.23
0.22
0.22
-0.03

0.14
1.48
-0.98
-1.17
-0.91
3.25**
2.51*
2.46*
2.69**
-0.51
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Table 8
Hierarchical model (Attitude): Effect of previous knowledge of Vasalgel, HBM constructs,
interpersonal factors, and perceived social norms on attitude towards Vasalgel
Unstandardized
estimate (SE)
Step 1
Intercept
Heard of Vasalgel previously
Step 2
Intercept
Heard of Vasalgel previously
Perceived Susceptibility
Perceived Severity
Perceived Benefits
Perceived Barriers
Self-efficacy
∆R2 = 0.34 ∆F = 10.05 p < 0.01
Step 3
Intercept
Heard of Vasalgel previously
Perceived Susceptibility
Perceived Severity
Perceived Benefits
Perceived Barriers
Self-efficacy
Perceived Social Norms
Interpersonal Factors
∆R2 = 0.003 ∆F = -0.2 p = 0.82
* p < 0.05
** p < 0.01

6.13 (0.31)
-0.76 (0.19)

Standardized
estimate

t-value

-0.41

20.12**
-4.01**

2.58 (1.23)
-0.07 (0.19)
-0.09 (0.17)
0.02 (0.08)
0.45 (0.11)
0.09 (0.09)
0.12 (0.10)

-0.04
-0.05
0.03
0.52
0.11
0.14

2.09*
-0.36
-0.54
0.31
4.1**
0.97
1.25

2.91 (1.36)
-0.08 (0.19)
-0.08 (0.17)
0.01 (0.08)
0.45 (0.11)
0.09 (0.09)
0.13 (0.11)
-0.01 (0.09)
-0.62 (0.10)

-0.04
-0.04
0.02
0.54
0.11
0.14
-0.01
-0.05

2.14*
-0.42
-0.48
0.17
4.07**
0.95
1.21
-0.09
-0.62
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Discussion
Overview of key findings
Overall, attitudes of men in this sample show that they are generally receptive to the idea
of a new form of male birth control. Additionally, a large proportion of men (41%) claimed that
they would use Vasalgel if it came on the market, with positive intent classified as responses
ranging from “strongly agree” to “moderately agree.” This finding is consistent with previous
research, which has found that roughly 35% to 70% of men report being willing to try a new
male contraceptive method (Heinemann et al., 2004; Keith et al., 1975).12 As research into male
contraception advances, findings that men would actually use a new method become more vital –
both to encourage rapid development of products and to understand how unwillingness to use a
new male contraceptive can be addressed.
The approach to understanding men’s attitudes towards and willingness to use Vasalgel
taken by this study was to build research around a theoretical model that has been shown
previously to predict and understand health behavior: the HBM. Confirming the primary
research hypothesis, the HBM was able to significantly predict both intent to use Vasalgel and
attitudes towards it. This finding indicates that the HBM is an appropriate lens through which
men’s contraceptive intentions and attitudes can be examined.
Consistent with previous research on the HBM, perceived barriers, perceived benefits,
and self-efficacy were all significant predictors of intent to use Vasalgel within the full model.
Notably, perceived susceptibility and perceived severity did not individually contribute. Within
the model of this study, intent to use Vasalgel is based largely on a consideration of the
12

Willingness to use varies widely depending on men’s age and country of origin, so the findings of the current
study are not out of the ordinary.
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perceived benefits and barriers of the contraceptive, as well as individual self-efficacy and
perceived social norms specific to Vasalgel. Benefits of Vasalgel are high effectiveness, length
of potential use, and ease of use. On the other hand, barriers to using Vasalgel include fear of
side effects or infertility and fear of pain at injection site. Although self-efficacy, the belief that
one is capable of taking action, is often contested in its role as a predictor of contraceptive use,
Strecher et al. (1986) asserts that as long as a self-efficacy measure is tailored to the specific
health behavior, it is appropriate to include the construct. In fact, the finding that self-efficacy is
associated with higher intent to use Vasalgel corresponds the literature on the role of selfefficacy in contraceptive use (e.g., Baele, Dusseldorp & Maes, 2001).
In the context of previous research on the HBM, the finding that perceived susceptibility
and severity do not independently predict contraceptive intentions is not unusual. Past research
examining the relationship between perceived susceptibility to and perceived severity of
pregnancy and contraceptive use has occasionally yielded inconsistent results. Among young,
low-income women, perceived susceptibility to pregnancy did not seem to have any impact on
use of contraception, safer sex, or the rate of subsequent unintended pregnancies (Rahman,
Berenson, & Herrera, 2013). In addition, in some cases neither worrying about the possibility of
pregnancy (Schofield, 1965) nor fear of pregnancy (Sorensen, 1973) were shown to have
significant effects on contraceptive use among adolescents in the United States.13 Furthermore,
self-rated importance of avoiding pregnancy was not significantly associated with LARC use
among young unmarried women in the United States (Dempsey et al., 2011). It is thus unclear as
to whether perceived susceptibility and severity are useful components of the HBM in research
concerning contraceptive use.
13

Although worry and fear appear as distinct concepts in these articles, both fall under the heading of perceived
severity of pregnancy in the context of the HBM.
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One further aspect of the data which could have affected the independent significance of
perceived severity and susceptibility was the finding that the mean scores for perceived
susceptibility (5.77) and perceived severity (5.94) are extremely close to the highest possible
score (6). These results may have caused a ceiling effect and prevented the subscales from
contributing significantly to the model. This effect may be partially due to the relatively young
age of participants (M = 24), especially considering that younger age was associated with higher
levels of perceived severity.
In addition to intent to use, this study investigated men’s attitudes towards Vasalgel.
There was overall high acceptance of Vasalgel as a potential male contraceptive (67%). With
regard to attitude towards Vasalgel, the data support the primary hypothesis; the HBM was able
to predict attitudes towards Vasalgel beyond the influence of participant characteristics. It is
therefore possible that although most previous research utilizing the HBM has focused on health
behavior and intent, attitudes towards health behaviors may share some underlying psychosocial
constructs with intentions. On the other hand, it is important to note that only the subscale of
perceived benefits was able to predict attitudes independently of the full model.
With regard to intent to use, the data support the full model and thus the secondary
hypothesis of this study; the addition of perceived social norms and interpersonal-level factors to
the HBM significantly improved the predictive ability of the model. However, only perceived
social norms was independently significant in the full model including HBM constructs,
interpersonal factors, and social norms. As such it is unclear as to whether interpersonal-level
factors contributed to the model.
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The finding that perceived social norms significantly influences intent to use Vasalgel is
essential to future research on male contraception. Consistent with previous research by
Condelli (1986), the results of this study indicate that decisions involving contraceptive choice
are affected by perceptions of the opinions of family and friends. Thus, the findings of this study
indicate that the HBM can indeed be improved by the addition of social norms.
The finding that perceived social norms influence intent to use Vasalgel is an interesting
finding especially in the context of contraceptive research. Many studies on contraceptive
behavior are modeled either on constructs of the HBM (personal perceptions of the contraceptive
method and/or one’s own ability to use it) or on the social aspect of contraceptive use. This
study supports the merging of the two modes of thought. In combining the constructs of the
HBM and perceived social norms, it is possible to build a more complete understanding of
contraception intentions.
A potential ceiling effect could also have influenced the significance of interpersonallevel factors in the model for intent to use Vasalgel (M = 5.39). On the other hand, the failure of
interpersonal-level factors to contribute to the model could also be seen as further support of the
utility of using the HBM in research on male LARCs. The HBM generally focuses on how an
individual’s perceptions impact their personal health behavior attitudes and intentions, and does
not often take into account interpersonal factors outside of relationship status (as part of
participant characteristics). It is possible, therefore, that men in this study viewed the decision to
get Vasalgel as one independent of their partners. This is supported by previous research by
Heinemann et al. (2004), who found that in North America – as opposed to Europe – a
significant proportion of men (8 -12%) stated that they would make such a contraceptive
decision independently of their partners.
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With regard to attitude, the second hypothesis of this study was not supported. Although
the HBM was able to significantly predict attitudes towards Vasalgel, the addition of perceived
social norms and interpersonal-level factors to the model had no significant impact on attitude.
The results indicate that while the model developed for this study seems to be an appropriate lens
for research involving intent to use Vasalgel, it is possible that slightly different constructs affect
attitudes towards male contraception. It appears that whereas intent to use Vasalgel is affected
by how men’s perceptions of their peers’ attitudes and intentions, general attitudes towards
Vasalgel are independent of perceived social norms.
Interestingly, the only demographic characteristic that was significantly associated with
both intent to use and attitude was whether men had heard of Vasalgel or a similar injected male
contraceptive prior to taking the survey (44% had). This finding is open to multiple
interpretations. First, it is possible that men who were already interested in male contraception
had researched the topic and were excited about the possibilities. In other words, men who
already have favorable attitude and intentions towards male contraception may be driven to find
out more. A second interpretation is that upon coming across the idea of male contraception (for
example, in the newspaper or through a friend), men’s willingness to try it increased and attitude
became more positive. Consequently, exposure to information on Vasalgel and male
contraception may increase intent to use as well as attitude.
Limitations
The key limitation of this study was the multicollinearity seen between scales. As
mentioned in the results section, many of the subscales of this study were highly correlated with
each other. Although this did not influence the overall fit of the model, it may have caused other
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problems within the study. Multicollinearity interferes with determining the precise effect of
each predictor and makes it unclear as to whether the subscales were actually measuring distinct
factors. However, the fact that the model was significant despite the high intercorrelations
between the independent constructs indicates that the HBM is still a useful tool for examining
attitudes and intentions towards male contraception. A larger sample size or a more detailed
survey may have helped to avoid multicollinearity.
A second issue with the current research concerns the relatively low Cronbach’s alphas
for some of the subscales utilized. As mentioned in the results section, coefficients above 0.70
are considered acceptable (George and Mallery 2003), with coefficient closer to 1.0 indicating
progressively greater internal consistency of items. The scales for perceived susceptibility and
interpersonal factors had Cronbach’s alphas of 0.59 and 0.60, respectively, which indicates
questionable internal validity of those scales. The scale measuring perceived social norms had a
coefficient of 0.66, which approached acceptability but did not reach it. This is problematic
because it means that the items in these scales may not have been measuring one particular
construct or variable. It may also be an indication that these scales should be reexamined and
potentially adjusted in any future research using this model. However, previous studies using the
HBM as a framework have run analyses with scales that have Cronbach’s alphas ranging from 0.58 to
0.81 (Petosa & Jackson, 1991; Eisen, Zellman, & McAlister, 1992). This implies that among past
research on contraceptive intentions, the scales developed for this study have acceptable levels of internal
consistency.

The third limitation of this study concerns participant sampling and demographics. The
majority of men who completed the survey were relatively young (M = 24; SD = 5.5), which may
have affected some of the findings of this study. Although this study did not find that age was
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associated with attitudes towards or intent to use Vasalgel, contraceptive use has often been
found to vary with age (Baele, Dusseldorp & Maes, 2001). Additionally, this study surveyed
only Bard students and respondents from the Hudson Valley, both of which are very specific
populations. Bard College is an expensive (in comparison to other colleges and universities)
four-year liberal arts college whose students often have liberal political and social views.
Furthermore, local stores where flyers were put up self-selected themselves to be more liberal, as
not all businesses allowed flyers with the word ‘birth control’ to be placed. Considering that
class was a significant factor in previous studies on male LARCs (Balswick et al., 1972), it is
important to note that the way this survey was advertised may have caused a sampling bias. As
cultures even within the United States vary greatly, future studies on contraceptive developments
would benefit from surveying an even broader population.
Future Directions
In this study, men’s attitudes and intentions towards a novel contraceptive were
examined; it was beyond the scope of this senior project to investigate women’s attitudes.
Studies across a variety of cultures have found that women have generally positive attitudes
towards a male hormonal contraceptive (Glasier et al., 2000), indicating that women support the
development of a male hormonal contraceptive. Investigations into whether women would trust
men to use such a contraceptive have found conflicting results, however. Many women report
that they would trust a partner to use a male LARC (Glasier et al., 2000), but they have limited
trust that men would use it effectively (Eberhardt, Wersch, & Meikle, 2009). However,
women’s attitudes towards a non-hormonal injected contraceptive method for men have not been
assessed. Trust of effective use may be less of an issue in the case of an injected contraceptive,
as it would be injected by a doctor and thus not dependent on proper user behavior. In the event
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that a contraceptive like Vasalgel reaches the market, it is vital to assess women’s attitudes
towards it as well as men’s.
Future studies into women’s attitudes towards long-term male contraception could also
benefit from a framework such as the HBM. The benefit of using the HBM in research is that it
enables health workers to develop interventions and education programs that are designed to best
meet men’s and women’s needs. Once a male contraceptive is available to the general public,
the HBM can help to structure promotional campaigns – which will need to target both men and
women.
Conclusion
The current study makes a significant contribution to research into male contraceptive
behavior and attitudes by highlighting the relationship between individual perceptions of
contraception and actual contraceptive intentions with regard to Vasalgel. This was the first
study to apply a psychological framework to research on male contraceptive developments, and
as such it can guide future research towards an even deeper understanding of how men would
react (and act) if any new male contraceptive method, not only Vasalgel, were to reach the
market.
Furthermore, this study supports previous research (Heinemann et al., 2004) that a
significant proportion of men in the United States are willing to take on contraceptive
responsibility by using a new contraceptive method, a finding which is strengthened by the fact
that participants of this study were given a specific, tangible contraceptive method to base their
responses on. The evidence up to this point is a good indication that research and
pharmaceutical companies should be working towards a new male contraceptive method,
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regardless of whether it is Vasalgel or another method. Now that this study has supplied a
working framework upon which to base future research, it will be easier to investigate its
applicability to other potential male contraceptive methods such as a male oral contraceptive, or
a once a month shot.
This research is also important because it will enable services that try to increase
awareness to male contraception to frame their programs in a structured way in order to be as
effective as possible. The HBM has been used to inform the structuring of programs and
interventions in the past (Eisen, Zellman, & McAlister, 1992) and now it is clear that the model
can be applied to programs pertaining to male contraceptive developments as well. It is vital to
educate both men and women about their reproductive health, the contraceptive options that they
have available today, and options that are currently being researched. This is especially true in
connection with the finding that previous knowledge was the single predictive demographic
characteristic for both attitudes and intentions towards Vasalgel. If more men knew about
Vasalgel or similar contraceptive developments for men, it is possible that there would be more
pressure on pharmaceuticals to fund research into their development. Additionally, if men claim
that they are willing to use a long-term contraceptive now, it is likely that if it reaches the market
even more men (once they know about it and research it) will want to try the new method.
As I mentioned in the introduction, women’s reproductive health and services are of vital
importance. Given the topic of this study, it is crucial to note that developing and promoting
male contraception is likely to improve the reproductive health of women in at least two ways.
First, the burden of contraceptive responsibility would no longer rest so heavily on women. We
now know that many men would use a new LARC, which could mean that fewer women would
have to use birth control (if they are in long-term relationships). Second, if men have more
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options for birth control, they may be more inclined or encouraged to learn about reproductive
health. This would involve them more in family planning, improve conversations surrounding
sexual health, and could lead to the improvement of everyone’s sexual health. Access, accurate
knowledge, and communication are key – and would be supplemented by the development of a
new contraceptive.
Finally, this study lends support to the steadily growing literature on the importance of
involving men in conversations and research on reproductive health and family planning. As
men have been excluded from most current discussion surrounding reproductive health, it has
often been difficult to gauge men’s attitudes towards contraception and fertility control. This
study is one of several that suggest that it is time to bring men back into the dialogue. It provides
a strong indication that young men today are ready to shoulder some of the contraceptive
responsibility that has rested predominantly upon women in the last three-quarters of a century.
Both men and women deserve the right to reproductive health education, services, and
developments.
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Appendix A
Complete Survey
You will now be asked to answer some questions about your personal life, as well as your sexual
activity. You will be asked about sex and contraception.
In this survey, when any questions refer to 'sex' they are referring explicitly to vaginal
intercourse. In addition, when any questions refer to a 'woman' they are referring specifically to
a biological woman.
'Contraception' refers to the deliberate use of a method (artificial or not) to prevent pregnancy
as a result of sexual intercourse. One common example of a contraceptive method is condom
use.
5) How old are you? ____________
6) What is the highest level of education you have reached?
( ) Did not finish high school
( ) High school degree
( ) Undergraduate degree
( ) Graduate degree
7) What is your current employment status?
( ) Student
( ) Employed
( ) Unemployed
8) What college do you currently attend?
( ) Bard College
( ) New Paltz
( ) Columbia-Greene Community College
( ) Other - Write In: _________________________________________________
9) What is your current year in college?
( ) Freshman
( ) Sophomore
( ) Junior
( ) Senior
( ) 5th year
( ) Graduate student
10) Please check any and all forms of contraception you have knowledge of:
[ ] Condoms
[ ] "The pill"
[ ] Intra-uterine devices (IUD)
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[ ] Diaphragm
[ ] The rhythm method (only having sex when a female partner is not ovulating)
[ ] Withdrawal (pulling out before ejaculation)
11) Have you ever had sex with a woman?
( ) Yes
( ) No
12) When was the most recent time you had sex with a woman?
( ) In the past month
( ) In the past six months
( ) In the past year
( ) Over one year ago
13) On this occasion, did you (or your partner) use any method of contraception?
( ) Yes
( ) No
14) When you have sex, how often do you (or a partner) use a method of contraception?
( ) Always
( ) Often
( ) Sometimes
( ) Rarely
( ) Never
15) How many sexual partners have you had in the last year? ____________
16) How many sexual partners have you ever had? ____________
17) Do you currently have any children?
( ) Yes
( ) No
18) Do you intend to have children in the future?
( ) Yes
( ) No
( ) I don't know
19) What is your relationship status?
( ) Single
( ) Casual (or open) relationship
( ) Steady Relationship
( ) Living together
( ) Married
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20) Are you currently in an ongoing sexual relationship with a woman (regardless of relationship
with other men or women)?
( ) Yes
( ) No
21) When did this relationship begin?
( ) Less than one month ago
( ) Between one month and six months ago
( ) Between six months and one year ago
( ) Between one and five years ago
( ) More than five years ago
22) Please check any and all forms of contraception you (or your partner) currently use:
[ ] Condoms
[ ] The pill
[ ] Intra-uterine device (IUD)
[ ] Diaphragm
[ ] The rhythm method
[ ] Withdrawal
[ ] Other: _________________________________________________
23) During the last six months, how many times have you and your sexual partner discussed how
to prevent pregnancy?
( ) Never
( ) 1-3 times
( ) 4-6 times
( ) 7 or more times
The next series of statements have to do with contraceptive behavior and pregnancy. Please
respond with your primary partner in mind. Please indicate your answers on a scale from
“strongly agree” to “strongly disagree.
24) I am committed to my partner.
( ) Strongly disagree ( ) Moderately disagree
( ) Moderately agree ( ) Strongly agree

( ) Slightly disagree

( ) Slightly agree

*25) I do not talk about birth control with my partner.
( ) Strongly disagree ( ) Moderately disagree
( ) Slightly disagree
( ) Moderately agree ( ) Strongly agree

( ) Slightly agree

*26) I often feel embarrassed when talking about birth control with my partner.
( ) Strongly disagree ( ) Moderately disagree
( ) Slightly disagree ( ) Slightly agree
( ) Moderately agree ( ) Strongly agree
27) My partner is comfortable talking about birth control with me.
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( ) Strongly disagree
( ) Moderately agree

( ) Moderately disagree
( ) Strongly agree
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( ) Slightly disagree

( ) Slightly agree

28) My partner and I are actively trying to have a baby.
( ) Strongly disagree ( ) Moderately disagree
( ) Slightly disagree
( ) Moderately agree ( ) Strongly agree

( ) Slightly agree

Please read the following on a new birth control method for men (not yet on the market):
Vasalgel™ is similar to getting a vasectomy but with one significant advantage: research to date
shows that it is 100% reversible. Researchers achieve this feature by injecting a gel into the vas
deferens, rather than cutting the vas (as is done in vasectomy). The gel then hardens, forming a
semi-solid obstruction that prevents viable sperm from passing through. If a man wishes to
restore his fertility, whether after months or years, the gel is flushed out with another injection.
There are currently no known side effects of Vasalgel. However, as it is still in the early stages of
human testing, it is impossible to know definitively about any long-term consequences or side
effects of using Vasalgel.
29) Have you heard about Vasalgel (or a similar kind of injected contraceptive) before reading
about it here?
( ) Yes
( ) No
Now you will be asked about some of your opinions on Vasalgel. Please indicate your answers
on a scale from “strongly agree” to “strongly disagree.”
30) I think that Vasalgel is an important invention.
( ) Strongly disagree ( ) Moderately disagree
( ) Moderately agree ( ) Strongly agree

( ) Slightly disagree

( ) Slightly agree

31) Vasalgel should be put on the market as soon as possible.
( ) Strongly disagree ( ) Moderately disagree
( ) Slightly disagree
( ) Moderately agree ( ) Strongly agree

( ) Slightly agree

*32) The thought of using Vasalgel makes me uncomfortable.
( ) Strongly disagree ( ) Moderately disagree
( ) Slightly disagree
( ) Moderately agree ( ) Strongly agree

( ) Slightly agree

33) I would use Vasalgel if it became available.
( ) Strongly disagree ( ) Moderately disagree
( ) Moderately agree ( ) Strongly agree

( ) Slightly agree

( ) Slightly disagree

34) Using Vasalgel as a long-tem contraceptive method for me would be:
( ) Very Awful ( ) Awful
( ) Somewhat Awful ( ) Somewhat Nice ( ) Nice
Very Nice

()
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35) A woman can get pregnant the first time she has unprotected sex.
( ) Strongly disagree ( ) Moderately disagree
( ) Slightly disagree
( ) Moderately agree ( ) Strongly agree

( ) Slightly agree

*36) I cannot get a woman pregnant.
( ) Strongly disagree ( ) Moderately disagree
( ) Moderately agree ( ) Strongly agree

( ) Slightly agree

( ) Slightly disagree

*37) My physical health makes it more likely that I won't get a woman pregnant if we have
unprotected sex.
( ) Strongly disagree ( ) Moderately disagree
( ) Slightly disagree ( ) Slightly agree
( ) Moderately agree ( ) Strongly agree
38) I worry a lot about getting my sexual partner(s) pregnant.
( ) Strongly disagree ( ) Moderately disagree
( ) Slightly disagree
( ) Moderately agree ( ) Strongly agree

( ) Slightly agree

39) Getting a woman pregnant is one of the worst things that could happen at this stage in my
life.
( ) Strongly disagree ( ) Moderately disagree
( ) Slightly disagree ( ) Slightly agree
( ) Moderately agree ( ) Strongly agree
*40) My financial security would not be endangered if I got a woman pregnant.
( ) Strongly disagree ( ) Moderately disagree
( ) Slightly disagree ( ) Slightly agree
( ) Moderately agree ( ) Strongly agree
*41) I would be happy if I got a woman pregnant in the next six months.
( ) Strongly disagree ( ) Moderately disagree
( ) Slightly disagree
( ) Moderately agree ( ) Strongly agree

( ) Slightly agree

42) Problems I would experience from getting a woman pregnant would last a long time.
( ) Strongly disagree ( ) Moderately disagree
( ) Slightly disagree ( ) Slightly agree
( ) Moderately agree ( ) Strongly agree
43) If I got a woman pregnant, my whole life would change.
( ) Strongly disagree ( ) Moderately disagree
( ) Slightly disagree
( ) Moderately agree ( ) Strongly agree

( ) Slightly agree

44) The thought of impregnating a woman scares me.
( ) Strongly disagree ( ) Moderately disagree
( ) Slightly disagree
( ) Moderately agree ( ) Strongly agree

( ) Slightly agree

*45) If I got a woman pregnant my academic career would not be endangered.
( ) Strongly disagree ( ) Moderately disagree
( ) Slightly disagree ( ) Slightly agree
( ) Moderately agree ( ) Strongly agree
( ) Not applicable
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46) If I got a woman pregnant my job opportunities and professional career would be
endangered.
( ) Strongly disagree ( ) Moderately disagree
( ) Slightly disagree ( ) Slightly agree
( ) Moderately agree ( ) Strongly agree
47) I am confident Vasalgel is able to prevent pregnancy.
( ) Strongly disagree ( ) Moderately disagree
( ) Slightly disagree
( ) Moderately agree ( ) Strongly agree

( ) Slightly agree

48) I enjoy sex more when I know my partner cannot get pregnant.
( ) Strongly disagree ( ) Moderately disagree
( ) Slightly disagree
( ) Moderately agree ( ) Strongly agree

( ) Slightly agree

*49) My sexual response would be diminished if I used Vasalgel.
( ) Strongly disagree ( ) Moderately disagree
( ) Slightly disagree
( ) Moderately agree ( ) Strongly agree

( ) Slightly agree

50) Using Vasalgel would reduce my fear of getting a woman pregnant.
( ) Strongly disagree ( ) Moderately disagree
( ) Slightly disagree
( ) Moderately agree ( ) Strongly agree

( ) Slightly agree

51) I have a lot to gain by using Vasalgel.
( ) Strongly disagree ( ) Moderately disagree
( ) Moderately agree ( ) Strongly agree

( ) Slightly agree

( ) Slightly disagree

52) I am afraid that if I use Vasalgel it would affect my ability to have children later.
( ) Strongly disagree ( ) Moderately disagree
( ) Slightly disagree ( ) Slightly agree
( ) Moderately agree ( ) Strongly agree
53) I am worried about the side effects of Vasalgel.
( ) Strongly disagree ( ) Moderately disagree
( ) Slightly disagree
( ) Moderately agree ( ) Strongly agree

( ) Slightly agree

54) The fact that Vasalgel is injected into a sensitive part of my body would not deter me from
using it.
( ) Strongly disagree ( ) Moderately disagree
( ) Slightly disagree ( ) Slightly agree
( ) Moderately agree ( ) Strongly agree
55) I am afraid that getting Vasalgel would hurt me.
( ) Strongly disagree ( ) Moderately disagree
( ) Slightly disagree
( ) Moderately agree ( ) Strongly agree

( ) Slightly agree

*56) I am not worried that getting Vasalgel would cause me to be permanently infertile.
( ) Strongly disagree ( ) Moderately disagree
( ) Slightly disagree ( ) Slightly agree
( ) Moderately agree ( ) Strongly agree
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*57) Vasalgel would be worth getting (for me) even if the monetary cost is high.
( ) Strongly disagree ( ) Moderately disagree
( ) Slightly disagree ( ) Slightly agree
( ) Moderately agree ( ) Strongly agree
58) I am afraid that Vasalgel would affect my sex drive.
( ) Strongly disagree ( ) Moderately disagree
( ) Slightly disagree
( ) Moderately agree ( ) Strongly agree

( ) Slightly agree

*59) It would be difficult to tell a partner that I am going to get Vasalgel.
( ) Strongly disagree ( ) Moderately disagree
( ) Slightly disagree ( ) Slightly agree
( ) Moderately agree ( ) Strongly agree
60) I am confident that I could go to the doctor to get Vasalgel if it became available.
( ) Strongly disagree ( ) Moderately disagree
( ) Slightly disagree ( ) Slightly agree
( ) Moderately agree ( ) Strongly agree
*61) I would not insist on getting Vasalgel if a partner threatened to leave me if I got it.
( ) Strongly disagree ( ) Moderately disagree
( ) Slightly disagree ( ) Slightly agree
( ) Moderately agree ( ) Strongly agree
62) I feel capable of discussing the importance of using Vasalgel with a sex partner.
( ) Strongly disagree ( ) Moderately disagree
( ) Slightly disagree ( ) Slightly agree
( ) Moderately agree ( ) Strongly agree
63) I would get Vasalgel even if my partner did not want me to.
( ) Strongly disagree ( ) Moderately disagree
( ) Slightly disagree
( ) Moderately agree ( ) Strongly agree

( ) Slightly agree

*64) It is a woman's responsibility if she gets pregnant.
( ) Strongly disagree ( ) Moderately disagree
( ) Slightly disagree
( ) Moderately agree ( ) Strongly agree

( ) Slightly agree

65) I have no objection to contraception as long as my partner uses it and I don’t have to.
( ) Strongly disagree ( ) Moderately disagree
( ) Slightly disagree ( ) Slightly agree
( ) Moderately agree ( ) Strongly agree
66) Knowing about my partner’s use of birth control devices frees me of any thoughts about
pregnancy.
( ) Strongly disagree ( ) Moderately disagree
( ) Slightly disagree ( ) Slightly agree
( ) Moderately agree ( ) Strongly agree
67) It would be embarrassing for me to ask my doctor about Vasalgel.
( ) Strongly disagree ( ) Moderately disagree
( ) Slightly disagree
( ) Moderately agree ( ) Strongly agree
68) If Vasalgel becomes available, it will increase promiscuity in men.

( ) Slightly agree
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( ) Moderately agree

( ) Moderately disagree
( ) Strongly agree

62

( ) Slightly disagree

( ) Slightly agree

*69) My family and friends would make fun of me if I used Vasalgel.
( ) Strongly disagree ( ) Moderately disagree
( ) Slightly disagree
( ) Moderately agree ( ) Strongly agree

( ) Slightly agree

70) My male friends would encourage me to get Vasalgel if it became available.
( ) Strongly disagree ( ) Moderately disagree
( ) Slightly disagree ( ) Slightly agree
( ) Moderately agree ( ) Strongly agree
71) As far as I know, my male friends would be interested in using Vasalgel if it became
available.
( ) Strongly disagree ( ) Moderately disagree
( ) Slightly disagree ( ) Slightly agree
( ) Moderately agree ( ) Strongly agree
72) Who should take more responsibility for preventing pregnancy in a heterosexual
relationship?
( ) The male
( ) The female
( ) Both should take equal responsibility

* Reverse-coded
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Appendix E
IRB Proposal
When do you plan to begin collecting data for this project? (begin date): May 1st, 2015
When do plan to end your data collection for this project? (end date): October 30th, 2015
What is the title for your project?
Attitudes and Intentions Toward a Novel Long-acting Reversible Contraceptive for Men
Describe your research question briefly (250 words or less)
According to the research done by the Alan Guttmacher Institute, an estimated 210
million pregnancies currently occur throughout the world each year. About 38% of these
pregnancies are unplanned, and 22% end in abortion. Contraception and family planning
programs (especially in developing countries) overwhelmingly target women, leaving men, for
the most part, out of the discussion.

As of now, the only forms of male contraception on the

market are condoms and vasectomies. This is why for my senior project I am interested in
studying men’s attitudes and intentions towards a new method of male contraception not yet on
the market, called Vasalgel™. This method is a non-hormonal male contraceptive that involves
the injection of a polymer into the vas deferens and prevents viable sperm from passing through,
while allowing for the passage of seminal fluid.
This survey study will use the Health Belief Model (HBM) to determine how men’s
perceived susceptibility, perceived barriers, perceived benefits, and self-efficacy may affect
men’s attitudes and intentions towards a new, injected, long-acting, reversible contraceptive
method. I will also add two levels to the HBM in order to create a model that can better predict
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attitudes and intentions: social norms, and interpersonal level factors. These findings will
hopefully give some insight into whether young, college-aged men would be willing to take on
some of the contraceptive responsibility that has rested on their female counterparts since the
1960s.
Will your participants include individuals from specific populations (e.g., children, pregnant
women, prisoners, or the cognitively impaired)?
No
If your participants will include individuals from specific populations, please specify the
population(s) and briefly describe any special precautions you will use.
N/A
Briefly describe how you will recruit participants. (e.g., Who will approach participants? What
is the source of the participants?)
I will recruit participants at Bard College by advertising on campus using flyers including
the link to the survey (sent to irb@bard.edu). The flyers will be placed in areas where students
frequent often like the Bertelsmann Campus Center and Kline Commons. Furthermore professors
who believe the survey is related to their subject matter will send the link out to their classes.
Briefly describe the procedures you will be using to conduct your research. Include descriptions
of what tasks your participants will be asked to do, and about how much time will be expected of
each individual.
The participant will be asked to complete an online survey using Survey Gizmo (sample
questions sent to IRB@bard.edu) that will take 15-20 minutes. The first step of the survey will

HBM APPROACH TO A NOVEL MALE CONTRACEPTIVE

68

be the consent form (sent to IRB@bard.edu). If the participant consents to taking the survey, the
next section will be three screening questions asking their age, biological gender, and sexual
orientation. If they are older than 18, biologically male, and of self-reported heterosexual or
bisexual orientation, they will be prompted to continue onto the survey. If they do not fulfill any
or all of the requirements, they will be directed to a screen thanking them for their interest and
informing them that they did not qualify for the study. The first part of the survey will ask about
participant’s demographics and individual characteristics (e.g. year in college, relationship
status). Participants will then be asked to read a short description of Vasalgel™, and asked a
small number of questions as to their attitudes and intentions towards the contraceptive method.
Participants will subsequently be asked a series of questions designed to measure the principle
components of the Health Belief Model – perceived susceptibility, perceived benefits, perceived
barriers, and perceived self-efficacy. They will then answer a short series of questions on their
perceived social norms. In the last part of the survey participants will be asked in more detail
about their interpersonal relationships with dating partners (if applicable) and peers.
Completion of this survey will take no longer than 15-20 minutes. After the survey is
completed, the participant will be given an email address, created specifically for this study, that
they can send a message to saying “I have completed the study” in order to be entered into the
lottery for a chance to win one of four $25 Amazon gift cards. This method will ensure that the
collected data is no way attached to e-mail addresses of participants and therefore maintain
confidentiality.
Approximately how many individuals do you expect to participate in your study?
200 from Bard
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Please describe any risks and benefits your research may have for your participants.
One risk of this study may be emotional discomfort due to the personal nature of the
questions, specifically questions that examine sexual behaviors and attitudes towards
contraception. Eye-strain and impatience may also be experienced during the process. The
benefit of completing the survey is gaining knowledge and awareness about different
contraceptive methods, and new possibilities for the future of contraception. In order to address
possible emotional discomfort produced by the study, the debriefing statement will include
contact information for Health Services at Bard College. To further inform participants on
contraception and fulfill any curiosity they might develop throughout the survey, the debriefing
statement will also include links for websites containing information on numerous forms of
contraception.
Please include here the verbal description of the consent process (how you will explain the
consent form and the consent process to your participants):
Because this survey will be completed online, the consent process will be written. The
participant will click the link if it is sent to them via email. If they type it in, then they will be
directed to a web page that will state the objectives of the survey, their rights as a participant and
the benefits and risks of undertaking the survey. The participant will also be informed that if they
press next, they are agreeing to participate in the study and will be directed to the next step of the
survey which will be two screening questions, mentioned above in the procedure section. The
online consent form was sent to IRB@bard.edu
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If your project will require that you use only a verbal consent process (no written consent
forms), please describe why this process is necessary, how verbal consent will be obtained, and
any additional precautions you will take to ensure the confidentiality of your participants.
No.
What procedures will you use to ensure that the information your participants provide will
remain confidential?

The survey will be online using Survey Gizmo, which has numerous anti-hacking
measure, firewalls, and constant security checks. All information gained through Survey Gizmo
remains confidential. Participants will be given an email (psych1273@gmail.com) at the end of
the survey that they will be told to send a message to along the lines of “I completed your
survey” if they want to be entered into the lottery. This email account has been created
specifically for this study as well, will not be in any way connected to the data and will be
deleted as soon as the lottery is performed. There will be no way to connect the participant with
the specific survey they completed. To ensure further confidentiality, the data will be stored on
the computer of the principle investigator, which is password protected at all times. A password
will have to be entered in order to view the folder where the data is contained. There will be no
data on any personal computer. The only people who will have access to the data will be the
primary investigator, Aisha King and the Senior Project Advisor, Farnaz Kaighobadi.

Will it be necessary to use deception with your participants at any time during this research?
No.
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Informed Consent Form
Thank you for agreeing to participate in this research study!
Background: The purpose of this study is to investigate men’s reactions to a new form of long-lasting
male birth control method.
What you will do in this study: You will complete a confidential and anonymous online survey that will
take about 15-20 minutes to complete. This survey will introduce you to a new form of male birth control
(that is not yet on the market), and will ask you about your attitudes and intentions toward it. It will also
include questions about your opinions on contraception, and your sexual and contraceptive behavior.
Benefits: The benefit of completing this survey is gaining knowledge and awareness of different current
and future forms of birth control.
Compensation: If you choose, you can be entered into a lottery for a chance to win one of four $25
Amazon gift cards.
Risks: This study may cause emotional discomfort due to the personal nature of the questions,
specifically questions that examine sexual behaviors and attitudes towards contraception. Eye-strain and
impatience may also be experienced during the process.
Your rights as a participant: You participation is completely voluntary. You may quit the survey at any
time with no questions asked.
Any questions or concerns can be directed to the primary researcher, Aisha King (ak4628@bard.edu)
Anonymity: No personal or identifying information will be asked from you, and the survey is completely
anonymous. At the end of the survey, you will be given the option to enter a lottery by sending an email
confirming your participation in the study. This method will ensure that the data is in no way attached to
your email address and therefore will preserve your anonymity completely. Your identity will thus
remain anonymous, as there will be no possible way that your email address can be connected to your
survey responses.
You must be 18 years or older to participate.
If you have any questions about this research project, please contact the primary investigator Aisha King
at ak4628@bard.edu or the senior project advisor Farnaz Kaighobadi at fkaighob@bard.edu. If you have
questions about your rights as a research participant, please contact the Chair of the Bard College
Institutional Review Board; IRB@bard.edu.
To continue to the survey, please press:
“Yes, I consent to participate.”
If you do not wish to participate, please press:
“No, I do not consent.”
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Debriefing Statement
Title of Study: Attitudes and Intentions Toward a Novel Long-acting Reversible Contraceptive
for Men
Thank you for participating in this study!
The goal of this study is to investigate men’s attitudes and intentions towards a new form of male
contraception, Vasalgel™. In order to do this, a brief description of the contraceptive method
was provided. The survey was also designed to measure how perceived costs and benefits of
using this method might affect attitudes and intentions towards it (e.g. willingness to try it).
Given the high number of unplanned pregnancies that occur every year, and the fact that most
contraceptive responsibility rests on female shoulders, research into a longer lasting male form of
birth control is very important. The results of this study will hopefully give some insight into
what men think about such a method, whether or not men would take advantage of it, and why.
If you have any questions regarding the study or would like more information about it, please
contact Aisha King at ak4628@bard.edu.
If you feel that you are experiencing any adverse consequences from this study, or if you have
any questions about contraceptive methods, please contact Bard Health Services at (845) 7587433. If they cannot help immediately, they will be able to provide you with a list of
counseling/medical services in the area.
If you are interested in learning more about contraception or different forms of male and female
contraception here is a list of online resources you may find helpful:
Vasalgel™: https://www.parsemusfoundation.org/vasalgel-home/
Contraceptive methods: http://www.plannedparenthood.org/learn/birth-control
http://www.nhs.uk/Conditions/contraceptionguide/Pages/contraception.aspx
Birth control for men: http://www.plannedparenthood.org/learn/men/birth-control-men

Thank you again for your participation in this study.
Aisha King
Bard College
Ak4628@bard.edu

